Safety and efficacy of artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Ethiopia

East African Medical Journal

Volumn 82, Issue 8, 2005, Pages 387-390

  Jima, D ^a   Tesfaye, G ^a   Medhin, A ^b,c   Kebede, A ^b   Argaw, D ^b   Babaniyi, O ^b  

^a FEDERAL MINISTRY OF HEALTH   (Ethiopia)

^b WHO Country Office   (Ethiopia)

^c WHO Country Office for Ethiopia ^*  (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER; ARTEMISININ DERIVATIVE; BENFLUMETOL; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; DRUG COMBINATION; ETHIOPIA; FEMALE; HUMAN; INFANT; MALARIA FALCIPARUM; MALE; MULTICENTER STUDY; PRESCHOOL CHILD; PROSPECTIVE STUDY; SAFETY; TREATMENT OUTCOME;

ADOLESCENT; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; ETHANOLAMINES; ETHIOPIA; FEMALE; FLUORENES; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; PROSPECTIVE STUDIES; SAFETY; TREATMENT OUTCOME;

EID: 27544471730     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Tulu, A. In: Kloos, H. Z. A. Zein (editors). The Ecology of Health and Disease in Ethiopia. Westview Press. Boulder (Co) 1993: 341-352.
2. Mengesha, I., Nigatu, W., Woldegiorgis, M., et al. The 1991 malaria epidemics in Ethiopia with reference to the outbreak in Zway, Central Ethiopia. Ethio. J. Health Dev. 1998; (S)12: 69-74.
3. Alamirew, D. and Equbazghi, G. Determinants of symptomatic and asymptomatic malaria. Ethio. J. Health Dev. 1998; (S)12: 69-74.
4. Federal Ministry of Health (2001). National Five Years Strategic Plan for Malaria Control in Ethiopia 2001-2005.
5. World Health Organisation (2000). The use of anti-malarial drugs. Report of a WHO informal consultation. WHO/CDS/ RBM/2001; 33: 34-35.
6. Fabian, M., Álvaro, M., Gabriel, C., et al. Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria. Amer. J. Epidemiol. 2002; 156:230-238.
7. Van Vugt, M., Wilairatana, P., Gemperli, B., et al. Efficacy of six doses of artemether-lumefantrine (Benflumetol) in multidrug-resistant plasmodium falciparum malaria. Amer. J. Trop. Med. Hyg. 1999; 60: 936-942.
8. World Health Organization. Assessment and monitoring of anti-malarial drug efficacy for the treatment of uncomplicated falciparum malaria. WHO/HTM/RBM/2003; 50.
9. World Health Organization (2001). Anti-malarial drug combination therapy WHO/CDS/RBM/2001; 50.
10. Negash, K., Tesfaye, G., Guintran, J., et al. New patterns of malaria epidemics in the highlands of Ethiopia. (in press submitted to East Africa Medical Journal).
11. Lefevre, G., Looareesuwan, S., Treeprasertsuk, S., et al, A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand. Amer. J. Trop. Med. Hyg. 2001; 64: 247-256.
12. McGready, R., Cho, T., Keo, N.K., et al, Artemisinin antimalarials in pregnancy: A prospective treatment study of 539 episodes of multidrug-resistant plasmodium falciparum. Clin. Inf. Dis. 2001; 33: 2009-2016.
13. Van Vugt, M., Looareesuwan, S., Wilairatana, P., et al. Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 2000; 94:545-548.
14. Van Vugt, M., Ezzet, F., Nosten, F., et al. No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine. Amer. J. Trop. Med. Hyg. 1999; 61: 964-967.
15. Stephen, T. and Andrew, J. Audiometric changes associated with the treatment of uncomplicated falciparum malaria with coartemether. Trans. R. Soc. Trop. Med. Hyg. 2004; 98: 261-267
16. Omari, A.A.A., Preston, C. and Garner, P. Artemether-lumefantrine for treating uncomplicated falciparum malaria (Cochrane Review). In: The Cochrane Library, Issue 3, 2002. Oxford: Update Software.